A randomized Phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients
Open accessPublished version of a preprint
Abstract
Purpose: We hypothesized that autophagy inhibition would increase response to chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We performed a randomized controlled trial to assess the autophagy inhibitor hydroxychloroquine in combination with gemcitabine and nab-paclitaxel. Patients and Methods: Participants with potentially resectable tumors were randomized to two cycles of nab-paclitaxel and gemcitabine (PG) alone or with hydroxychloroquine (PGH), followed by resection. The primary endpoint was histopathologic response in the resected specimen. Secondary clinical endpoints included serum CA 19-9 biomarker response and margin negative R0 resection. Exploratory endpoints included markers of autophagy, immune infiltrate, and serum cytokines. Results: Thirty-four patients in the PGH arm and 30 in the PG arm were evaluable for the primary endpoint. The PGH arm demonstrated statistically improved Evans grade histopathologic responses (P = 0.00016), compared with control. In patients with elevated CA 19-9, a return to normal was associated with improved overall and recurrence-free survival (P < 0.0001). There were no differences in serious adverse events between arms and chemotherapy dose number was equivalent. The PGH arm had greater evidence of autophagy inhibition in their resected specimens (increased SQSTM1, P = 0.027, as well as increased immune cell tumor infiltration, P = 0.033). Overall survival (P = 0.59) and relapse-free survival (P = 0.55) did not differ between the two arms. Conclusions: The addition of hydroxychloroquine to preoperative gemcitabine and nab-paclitaxel chemotherapy in patients with resectable pancreatic adenocarcinoma resulted in greater pathologic tumor response, improved serum biomarker response, and evidence of autophagy inhibition and immune activity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hydroxychloroquine enhances PDAC patient response to chemotherapy.
“clinical trials have shown that hydroxychloroquine, which inhibits autophagic flux by preventing lysosomal acidification, enhances PDAC patient response to chemotherapy212,213”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Tumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230 · see citing works
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498 · see citing works
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259 · see citing works
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Amaravadi, R. K., Lippincott‐Schwartz, J., Yin, X., Weiss, W. A., Takebe, N., Timmer, W. C., DiPaola, R. S., Lotze, M. T., & White, E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2634 · Cited by 899 · see citing works
Self-citationTranscriptional control of autophagy-lysosome function drives pancreatic cancer metabolism
Perera, R. M., Stoykova, S., Nicolay, B. N., Ross, K. N., Fitamant, J., Boukhali, M., Lengrand, J., Deshpande, V., Selig, M. K., Ferrone, C. R., et al. (2015) · Nature · doi:10.1038/nature14587 · Cited by 799 · see citing works
Preoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas
Evans, D. B. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420110083017 · Cited by 771 · see citing works
Guo, J. Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S. C., Kamphorst, J. J., Strohecker, A. M., Chen, G., Price, S., Lu, W., Teng, X., et al. (2013) · Genes & Development · doi:10.1101/gad.219642.113 · Cited by 589 · see citing works
Haeno, H., Gönen, M., Davis, M. B., Herman, J. M., Iacobuzio–Donahue, C. A., & Franziska Michor, A. (2012) · Cell · doi:10.1016/j.cell.2011.11.060 · Cited by 408 · see citing works
Yang, A., Herter-Sprie, G., Zhang, H., Lin, E. Y., Biancur, D., Wang, X., Deng, J., Hai, J., Yang, S., Wong, K.-K., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0952 · Cited by 349 · see citing works
Breslin, T. M. (2001) · Annals of Surgical Oncology · doi:10.1245/aso.2001.8.2.123 · Cited by 310 · see citing works
Breslin, T. M., Hess, K. R., Harbison, D. B., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0123-4 · Cited by 302 · see citing works
Karasic, T. B., O’Hara, M. H., Loaiza‐Bonilla, A., Reiss, K. A., Teitelbaum, U. R., Borazanci, E. H., Jesus‐Acosta, A. D., Redlinger, C., Burrell, J. A., Laheru, D. A., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0684 · Cited by 296 · see citing works
Self-citationWurzer, B., Zaffagnini, G., Fracchiolla, D., Turco, E., Abert, C., Romanov, J., & Martens, S. (2015) · eLife · doi:10.7554/elife.08941 · Cited by 271 · see citing works
Chatterjee, D., Katz, M. H. G., Rashid, A., Varadhachary, G. R., Wolff, R. A., Wang, H., Lee, J. E., Pisters, P. W. T., Vauthey, J., Crane, C. H., et al. (2011) · Cancer · doi:10.1002/cncr.26651 · Cited by 260 · see citing works
Aziz, M. H., Sideras, K., Aziz, N. A., Mauff, K. A. L., Haen, R., Roos, D., Saida, L., Suker, M., van der Harst, E., Mieog, J. S. D., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002660 · Cited by 259 · see citing works
Boone, B. A., Bahary, N., Zureikat, A. H., Moser, A. J., Normolle, D. P., Wu, W.-C., Singhi, A. D., Bao, P., Bartlett, D. L., Liotta, L. A., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4566-4 · Cited by 234 · see citing works
Self-citationPractical Bayesian adaptive randomisation in clinical trials
Thall, P. F., & Wathen, J. K. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.006 · Cited by 230 · see citing works
Tempero, M. A., Reni, M., Riess, H. B., Pelzer, U., O'Reilly, E. M., Winter, J. M., Oh, D., Li, C., Tortora, G., Chang, H.-M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.4000 · Cited by 141 · see citing works
Bauer, T. M., El‐Rayes, B. F., Li, X., Hammad, N., Philip, P. A., Shields, A. F., Zalupski, M. M., & Bekaii‐Saab, T. (2012) · Cancer · doi:10.1002/cncr.27734 · Cited by 130 · see citing works
Hashimoto, D., Bläuer, M., Hirota, M., Ikonen, N. H., Sand, J. A., & Laukkarinen, J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.011 · Cited by 116 · see citing works
Dauer, P., Zhao, X., Gupta, V. K., Sharma, N., Kesh, K., Gnamlin, P., Dudeja, V., Vickers, S. M., Banerjee, S., & Saluja, A. K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2320 · Cited by 115 · see citing works
Chiorean, E. G., Hoff, D. D. V., Reni, M., Arena, F. P., Infante, J. R., Bathini, V., Wood, T. E., Mainwaring, P. N., Muldoon, R. T., Clingan, P., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw006 · Cited by 106 · see citing works
Pardo, R. P., Ré, A. L., Archange, C., Ropolo, A., Papademetrio, D. L., González, C. D., Alvarez, E. M. D. C., Iovanna, J., & Vaccaro, M. I. (2010) · Pancreatology · doi:10.1159/000264680 · Cited by 97 · see citing works
The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation
Tsujimura (2010) · International Journal of Oncology · doi:10.3892/ijo_00000732 · Cited by 94 · see citing works
A critical role for autophagy in pancreatic cancer
Yang, S., & Kimmelman, A. C. (2011) · Autophagy · doi:10.4161/auto.7.8.15762 · Cited by 89 · see citing works
High immune cell score predicts improved survival in pancreatic cancer
Tahkola, K., Mecklin, J., Wirta, E., Ahtiainen, M., Helminen, O., Böhm, J., & Kellokumpu, I. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2297-1 · Cited by 79 · see citing works
Thakur, P. C., Miller-Ocuin, J. L., Nguyen, K., Matsuda, R., Singhi, A. D., Zeh, H. J., & Bahary, N. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1562-z · Cited by 71 · see citing works
Self-citationMET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
Modica, C., Tortarolo, D., Comoglio, P. M., Basilico, C., & Vigna, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123920 · Cited by 42 · see citing works
Vogel, S., Börger, V., Peters, C., Förster, M., Liebfried, P., Metzger, K., Meisel, R., Däubener, W., Trapp, T., Fischer, J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.225 · Cited by 41 · see citing works
Autophagy Inhibition in Pancreatic Adenocarcinoma
Boone, B. A., Zeh, H. J., & Bahary, N. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.10.013 · Cited by 41 · see citing works
Self-citationYang, X., Liu, S., Xu, J., Cao, S.-G., Li, Y., & Zhou, Y. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.027 · Cited by 37 · see citing works
Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy
Chi, K.-H., Wang, Y., Huang, Y.-C., Chiang, H.-C., Chi, M., Chi, C., Wang, H.-E., & Kao, S.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.10873 · Cited by 30 · see citing works
Bao, P. Q., Potter, D. M., Eisenberg, D. P., Lenzner, D. E., Zeh, H. J., Lee, K. K. W., Hughes, S. J., Sanders, M. K., Young, J. L., & Moser, A. J. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00110.x · Cited by 26 · see citing works
Self-citationCrizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer
Takiguchi, S., Inoue, K., Matsusue, K., Furukawa, M., Teramoto, N., & Iguchi, H. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3992 · Cited by 19 · see citing works
Regine, W. F., Winter, K. A., Abrams, R. A., Safran, H. P., Kessel, I. L., Chen, Y., Fugazzi, J. A., Donnelly, E. D., DiPetrillo, T. A., Narayan, S., et al. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.01.003 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Yamamoto, K., Venida, A., Yano, J., Biancur, D. E., Kakiuchi, M., Gupta, S., Sohn, A. S. W., Mukhopadhyay, S., Lin, E. Y., Parker, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2229-5 · Cited by 1,240 · see citing works
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529 · see citing works
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 411 · see citing works
Cell death in pancreatic cancer: from pathogenesis to therapy
Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 339 · see citing works
Self-citationMetabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 342 · see citing works
Targeting lysosomes in human disease: from basic research to clinical applications
Cao, M., Luo, X., Wu, K., & He, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00778-y · Cited by 225 · see citing works
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Zhao, S., Tang, Y., Wang, R., & Najafi, M. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01750-z · Cited by 187 · see citing works
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 180 · see citing works
Regulation and function of autophagy in pancreatic cancer
Li, J., Chen, X., Kang, R., Zeh, H. J., Klionsky, D. J., & Tang, D. (2020) · Autophagy · doi:10.1080/15548627.2020.1847462 · Cited by 160 · see citing works
Self-citationCellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
Li, J., Kang, R., & Tang, D. (2021) · Cancer Communications · doi:10.1002/cac2.12188 · Cited by 123 · see citing works
Self-citationRecent advances in targeting autophagy in cancer
Jain, V., Singh, M. P., & Amaravadi, R. K. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.02.003 · Cited by 131 · see citing works
Self-citationMetabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 127 · see citing works
Koltai, T., Reshkin, S. J., Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Alfarouk, K. O., & Cardone, R. A. (2022) · Cancers · doi:10.3390/cancers14102486 · Cited by 107 · see citing works
Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review
Mohsen, S. T., Sobash, P. T., Algwaiz, G., Nasef, N., Al-Zeidaneen, S. A., & Karim, N. A. (2022) · Current Oncology · doi:10.3390/curroncol29030141 · Cited by 101 · see citing works
Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines
Chen, J., Wu, X., Yin, D., Jia, X.-H., Chen, X., Gu, Z., & Zhu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108485 · Cited by 92 · see citing works
Luo, P., An, Y., He, J., Xing, X., Zhang, Q., Liu, X., Chen, Y., Yuan, H., Chen, J., Wong, Y., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216621 · Cited by 88 · see citing works
Mukhopadhyay, S., Biancur, D. E., Parker, S. J., Yamamoto, K., Banh, R. S., Paulo, J. A., Mancias, J. D., & Kimmelman, A. C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021475118 · Cited by 80 · see citing works
Gu, Z., Du, Y., Zhao, X., & Wang, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.029 · Cited by 78 · see citing works
Ashrafizadeh, M., Zhang, W., Zou, R., Sethi, G., Klionsky, D. J., & Zhang, X. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106822 · Cited by 79 · see citing works
Impact of context-dependent autophagy states on tumor progression
Assi, M., & Kimmelman, A. C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00546-7 · Cited by 75 · see citing works
Leroux, C., & Konstantinidou, G. (2021) · Cancers · doi:10.3390/cancers13040799 · Cited by 76 · see citing works
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Mohindroo, C., Hasanov, M., Rogers, J. E., Dong, W., Prakash, L. R., Baydogan, S., Mizrahi, J. D., Overman, M. J., Varadhachary, G. R., Wolff, R. A., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3870 · Cited by 73 · see citing works
Self-citationPatergnani, S., Missiroli, S., Morciano, G., Perrone, M., Mantovani, C. M., Anania, G., Fiorica, F., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13225622 · Cited by 72 · see citing works
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alkazmi, L. M., Habotta, O. A., & Batiha, G. E. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00988-y · Cited by 71 · see citing works
Xu, C., Huang, X., Hu, Q., Xue, W., Zhou, K., Li, X., Nan, Y., Ju, D., Wang, Z., & Zhang, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117550 · Cited by 71 · see citing works
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Maggs, L., Sadagopan, A., Moghaddam, A. S., & Ferrone, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.07.006 · Cited by 71 · see citing works
Mehnert, J. M., Mitchell, T. C., Huang, A. C. C., Aleman, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3382 · Cited by 68 · see citing works
Self-citationTargeting PIKfyve-driven lipid metabolism in pancreatic cancer
Cheng, C., Hu, J., Mannan, R., He, T., Bhattacharyya, R., Magnuson, B., Wisniewski, J. P., Peters, S., Karim, S., MacLean, D. J., et al. (2025) · Nature · doi:10.1038/s41586-025-08917-z · Cited by 61 · see citing works
Autophagy in cancer resistance to paclitaxel: Development of combination strategies
Škubník, J., Pavlíčková, V. S., Ruml, T., & Rimpelová, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114458 · Cited by 65 · see citing works
Mukhopadhyay, S., Encarnación-Rosado, J., Lin, E. Y., Sohn, A. S. W., Zhang, H., Mancias, J. D., & Kimmelman, A. C. (2023) · Science Advances · doi:10.1126/sciadv.adf9284 · Cited by 65 · see citing works
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 69 · see citing works
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy
Zada, S., Hwang, J. S., Ahmed, M., Lai, T. H., Pham, T. M., Elashkar, O., & Kim, D. R. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188565 · Cited by 64 · see citing works
Tang, Y., Wang, L., Yi, T., Xu, J., Wang, J., Qin, J., Chen, Q., Yip, K.-M., Pan, Y., Peng, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.007 · Cited by 60 · see citing works
Lysosomal lipid peroxidation regulates tumor immunity
Bhardwaj, M., Lee, J. J., Versace, A. M., Harper, S. L., Goldman, A. R., Crissey, M. A. S., Jain, V., Singh, M. P., Vernon, M., Aplin, A. E., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164596 · Cited by 61 · see citing works
Self-citationHacking Pancreatic Cancer: Present and Future of Personalized Medicine
Federico, A. D., Tateo, V., Parisi, C., Formica, F., Carloni, R., Frega, G., Rizzo, A., Ricci, D., Marco, M. D., Palloni, A., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14070677 · Cited by 60 · see citing works
Jahangiri, B., Saei, A. K., Obi, P. O., Asghari, N., Lorzadeh, S., Hekmatirad, S., Rahmati, M., Velayatipour, F., Asghari, M. H., Saleem, A., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166484 · Cited by 60 · see citing works
Autophagy in Cancer Immunotherapy
Lei, Y., Zhang, E., Bai, L., & Li, Y. (2022) · Cells · doi:10.3390/cells11192996 · Cited by 57 · see citing works
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication
Rayner, J. O., Roberts, R. A., Kim, J., Poklepovic, A. S., Roberts, J. L., Booth, L. A., & Dent, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114227 · Cited by 56 · see citing works
KRAS: the Achilles’ heel of pancreas cancer biology
Drizyte‐Miller, K., Talabi, T., Somasundaram, A., Cox, A. D., & Der, C. J. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191939 · Cited by 63 · see citing works
Yang, J. Z., Liu, Y., & Liu, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06032-3 · Cited by 56 · see citing works
Li, S., Wang, A., Wu, Y., He, S., Wen, S., Zhao, M., Zhu, Y., Hu, X., Luo, Y., & Wang, G. (2023) · Immunological Reviews · doi:10.1111/imr.13274 · Cited by 57 · see citing works
Anand, K., Niravath, P. A., Patel, T., Ensor, J., Rodriguez, A. A., Boone, T., Wong, S. T. C., & Chang, J. C. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.09.015 · Cited by 54 · see citing works
Pratt, H. G., Steinberger, K. J., Mihalik, N. E., Ott, S., Whalley, T., Szomolay, B., Boone, B. A., & Eubank, T. D. (2021) · Cancers · doi:10.3390/cancers14010194 · Cited by 51 · see citing works
Self-citationBai, Z., Peng, Y., Ye, X., Liu, Z., Li, Y., & Ma, L. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100804 · Cited by 53 · see citing works
Sadagopan, A., Michelakos, T. P., Boyiadzis, G., Ferrone, C. R., & Ferrone, S. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.5970 · Cited by 49 · see citing works
Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184351 · Cited by 48 · see citing works
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
Agalakova, N. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020945 · Cited by 48 · see citing works
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
de Jesus, V. H. F., Mathias-Machado, M. C., de Farias, J. P. F., Aruquipa, M. P. S., Jacome, A. A. D. A., & Peixoto, R. D. (2023) · Cancers · doi:10.3390/cancers15205015 · Cited by 47 · see citing works
Ivey, A. D., Fagan, B. M., Murthy, P., Lotze, M. T., Zeh, H. J., Hazlehurst, L., Geldenhuys, W. J., & Boone, B. A. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad005 · Cited by 45 · see citing works
Self-citationXie, Q., Chen, Y., Tan, H., Liu, B., Zheng, L., & Mu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.748149 · Cited by 44 · see citing works
Autophagy and cancer: Basic mechanisms and inhibitor development
Hama, Y., Ogasawara, Y., & Noda, N. N. (2023) · Cancer Science · doi:10.1111/cas.15803 · Cited by 44 · see citing works
Wang, X., Shang, M., Sun, X. Y., Guo, L., Xiao, S., Shi, D., Meng, D., Zhao, Y., Yang, L., Jiang, C., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.009 · Cited by 41 · see citing works
De Lellis, L., Veschi, S., Tinari, N., Mokini, Z., Carradori, S., Brocco, D., Florio, R., Grassadonia, A., & Cama, A. (2021) · Cancers · doi:10.3390/cancers13163946 · Cited by 40 · see citing works
Recent advances in targeted therapy for pancreatic adenocarcinoma
Fang, Y., Yang, W., Niu, Y., & Sun, Y. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i4.571 · Cited by 39 · see citing works
Bao, Y., Qiao, Y., Choi, J. E., Zhang, Y., Mannan, R., Cheng, C., He, T., Zheng, Y., Yu, J., Gondal, M. N., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314416120 · Cited by 39 · see citing works
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
Gillson, J., El-Aziz, Y. S. A., Leck, L. Y. W., Jansson, P. J., Pavlakis, N., Samra, J. S., Mittal, A., & Sahni, S. (2022) · Cancers · doi:10.3390/cancers14143528 · Cited by 38 · see citing works
Abdel‐Aziz, A. K., Saadeldin, M. K., Salem, A. H., Ibrahim, S. A.-S., Shouman, S. A., Abdel‐Naim, A. B., & Orecchia, R. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2040028 · Cited by 37 · see citing works
Hashemi, M., Paskeh, M. D. A., Orouei, S., Abbasi, P., Khorrami, R., Dehghanpour, A., Esmaeili, N., Ghahremanzade, A., Zandieh, M. A., Peymani, M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114546 · Cited by 37 · see citing works
HMGB1/RAGE axis in tumor development: unraveling its significance
Fan, A., Gao, M., Tang, X., Jiao, M., Wang, C., Wei, Y., Gong, Q., & Zhong, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1336191 · Cited by 42 · see citing works
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Reyes‐Castellanos, G., Hadi, N. A., & Carrier, A. (2022) · Cells · doi:10.3390/cells11030426 · Cited by 38 · see citing works
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition
Jain, V., Harper, S. L., Versace, A. M., Fingerman, D. F., Brown, G. S., Bhardwaj, M., Crissey, M. A. S., Goldman, A. R., Ruthel, G. T., Liu, Q., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0535 · Cited by 37 · see citing works
Self-citationThe Autophagic Route of E-Cadherin and Cell Adhesion Molecules in Cancer Progression
Santarosa, M., & Maestro, R. (2021) · Cancers · doi:10.3390/cancers13246328 · Cited by 37 · see citing works
Chauhan, N., & Patro, B. S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216599 · Cited by 31 · see citing works
Gastman, B., Agarwal, P. K., Berger, A., Boland, G. M., Broderick, S., Butterfield, L. H., Byrd, D. R., Fecci, P. E., Ferris, R. L., Fong, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001583 · Cited by 37 · see citing works
Self-citationThe role of autophagy in pancreatic cancer progression
Wang, Y., Qin, C., Yang, G., Zhao, B., & Wang, W. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188592 · Cited by 35 · see citing works
Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
Tian, Z., & Yao, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.815900 · Cited by 33 · see citing works
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
Karasic, T. B., Brown, T. J., Schneider, C. J., Teitelbaum, U. R., Reiss, K. A., Mitchell, T. C., Massa, R. C., O’Hara, M. H., Dicicco, L., Garcia-Marcano, L., et al. (2022) · The Oncologist · doi:10.1093/oncolo/oyac078 · Cited by 33 · see citing works
Self-citationAutophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 33 · see citing works
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors
Komarla, A., Dufresne, S., & Towers, C. G. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad001 · Cited by 35 · see citing works
Hassan, S., Awasthi, N., Ponna, S., & von Holzen, U. W. (2023) · Biomedicines · doi:10.3390/biomedicines11072000 · Cited by 31 · see citing works
Jia, H., Wei, J., Zheng, W., & Li, Z. Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06595-z · Cited by 32 · see citing works
The relationship between autophagy and PD-L1 and their role in antitumor therapy
Cui, Y., Shi, J., Cui, Y., Zhu, Z., & Zhu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1093558 · Cited by 30 · see citing works
Fei, N., Wen, S., Ramanathan, R., Hogg, M. E., Zureikat, A. H., Lotze, M. T., Bahary, N., Singhi, A. D., Zeh, H. J., & Boone, B. A. (2021) · Clinical and Translational Science · doi:10.1111/cts.13029 · Cited by 31 · see citing works
Self-citationStoica, A.-F., Chang, C., & Pauklin, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.008 · Cited by 30 · see citing works
Targeting autophagy as a therapeutic strategy against pancreatic cancer
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01889-1 · Cited by 29 · see citing works
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Strippoli, R., Niayesh‐Mehr, R., Adelipour, M., Khosravi, A., Cordani, M., Zarrabi, A., & Allameh, A. (2024) · Cancers · doi:10.3390/cancers16040807 · Cited by 29 · see citing works
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
Ganzleben, I., Neurath, M. F., & Becker, C. (2021) · Cancers · doi:10.3390/cancers13215575 · Cited by 28 · see citing works
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Sanctis, J. B. D., Charris, J., Blanco, Z., Ramírez, H., Martinez, G. P., & Mijares, M. R. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220519102948 · Cited by 29 · see citing works
Watson, M. D., Miller-Ocuin, J. L., Driedger, M. R., Beckman, M. J., McKillop, I. H., Baker, E. H., Martinie, J. B., Vrochides, D. V., Iannitti, D. A., & Ocuin, L. M. (2020) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2020.0011 · Cited by 26 · see citing works
Self-citationAutophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions
Martins, W. K., Silva, M. N., Pandey, K. R., Maejima, I., Ramalho, E. D. S., Olivon, V. C., Diniz, S. N., & Grasso, D. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100033 · Cited by 26 · see citing works
AlMasri, S. S., Zenati, M. S., DeSilva, A., Nassour, I., Boone, B. A., Singhi, A. D., Bartlett, D. L., Liotta, L. A., Espina, V. A., Loughran, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4211 · Cited by 26 · see citing works
Self-citationMaddipati, R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191943 · Cited by 26 · see citing works
Ropolo, A., Catrinacio, C., Renna, F. J., Boggio, V., Orquera, T., González, C. D., & Vaccaro, M. I. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00411 · Cited by 25 · see citing works
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Ye, T., Ge, Y., Jiang, X., Song, H., Peng, C., & Liu, B. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00811-y · Cited by 25 · see citing works
Drug Resistance in Cancers: A Free Pass for Bullying
Li, J., Li, X., & Guo, Q. (2022) · Cells · doi:10.3390/cells11213383 · Cited by 24 · see citing works
Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers
Bi, J., Witt, E., McGovern, M. K., Cafi, A. B., Rosenstock, L., Pearson, A. B., Brown, T. J., Karasic, T. B., Absler, L. C., Manchkanti, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202308346 · Cited by 24 · see citing works
The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
Liu, B., Lu, Y., Taledaohan, A., Qiao, S., Li, Q., & Wang, Y. (2023) · Molecules · doi:10.3390/molecules29010075 · Cited by 24 · see citing works
Chen, C., Pan, K., Wu, B., Li, X., Chen, Z., Xu, Q., Lv, Q., & Lv, Q. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02962-5 · Cited by 23 · see citing works
Olszewska, A., Borkowska, A., Granica, M., Karolczak, J., Zglinicki, B., Kiéda, C., & Waś, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.738385 · Cited by 23 · see citing works
DeLiberty, J. M., Roach, M. K., Stalnecker, C. A., Robb, R. N., Schechter, E. G., Pieper, N. L., Taylor, K. E., Pita, L. M., Yang, R. Y., Bang, S., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-1757 · Cited by 27 · see citing works
Novel approaches to clinical trial design in cancer neuroscience
Jones, G., Anderson, J. L., Nguyen, P. T., Gleber‐Netto, F. O., Hwang, W. L., Puduvalli, V. K., Monje, M., & Amit, M. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.015 · Cited by 23 · see citing works
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma
Augello, G., Emma, M. R., Azzolina, A., Puleio, R., Condorelli, L., Cusimano, A., Giannitrapani, L., McCubrey, J. A., Iovanna, J., & Cervello, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.026 · Cited by 21 · see citing works
Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy
Liu, Y., Meng, Y., Zhang, J., Gu, L., Shen, S., Zhu, Y., & Wang, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s458910 · Cited by 20 · see citing works
Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance
Niharika, N., & Garg, M. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.23 · Cited by 20 · see citing works
Xu, H., Tan, M., Hou, G., Sang, Y.-Z., Lin, L., Gan, X.-C., Cao, X., & Liu, A. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06344-4 · Cited by 20 · see citing works
The Interplay between Autophagy and Mitochondria in Cancer
Zdanowicz, A., & Grosicka-Maciąg, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179143 · Cited by 21 · see citing works
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
Niemann, B. R., Puleo, A., Stout, C., Markel, J., & Boone, B. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122551 · Cited by 19 · see citing works
Self-citationAutophagy Modulators in Cancer: Focus on Cancer Treatment
Nam, H. J. (2021) · Life · doi:10.3390/life11080839 · Cited by 19 · see citing works
Nagaraju, G. P., Saddala, M. S., Foote, J. B., Khaliq, A. M., Masood, A., Golivi, Y., Bandi, D. S. R., Sarvesh, S., Reddy, S. P., Switchenko, J. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101881 · Cited by 19 · see citing works
- Authors
- Zeh, H. J., Bahary, N., Boone, B. A., Singhi, A. D., Miller-Ocuin, J. L., Normolle, D. P., Zureikat, A. H., Hogg, M. E., Bartlett, D. L., Lee, K. K., Tsung, A., Marsh, J. W., Murthy, P., Tang, D., Seiser, N., Amaravadi, R. K., Espina, V., Liotta, L., & Lotze, M. T.
- Affiliations
- University of Pittsburgh (US)
- St Vincent Medical Center (US)
- University of Pennsylvania (US)
- George Mason University (US)
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2020-07-01
- Volume
- 26
- Issue
- 13
- Pages
- 3126-3134
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- PMC
- PMC8086597
- OpenAlex
- W3010751808
- Cited by
- 233
- References
- 34
- Citations by year
- 2026: 31 · 2025: 34 · 2024: 33 · 2023: 43 · 2022: 36 · 2021: 38 · 2020: 18
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (1R01 CA181450, R01GM115366, R01CA206012)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic ductal adenocarcinoma, autophagy inhibition, hydroxychloroquine, gemcitabine, nab-paclitaxel, neoadjuvant chemotherapy, resectable pancreatic cancer, CA19-9, p62, tumor-infiltrating immune cells, R0 resection, overall survival, relapse-free survival
- MeSH terms
- Gemcitabine, Adult, Aged, Aged, 80 and over, Albumins, Antineoplastic Combined Chemotherapy Protocols, Autophagy, Deoxycytidine, Female, Humans, Hydroxychloroquine, Male, Middle Aged, Neoplasm Staging, Pancreatic Neoplasms, Preoperative Care, Recurrence, Survival Analysis, Treatment Outcome, Paclitaxel, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
